Funder: European Commission
Due Dates: April 16, 2026
Funding Amounts: €6M–€8M per project (lump sum); approx. 4 grants available
Summary: Supports follow-on funding to accelerate EU-funded regenerative medicine innovations from preclinical validation to clinical development and deployment.
Key Information: Proposals must build on results from a completed multi-beneficiary Horizon 2020/Horizon Europe project (not MSCA or ongoing projects).